Back to Search
KATHRYN PONDER, MD
MD
Neonatal-Perinatal Medicine Physician
NPI: 1649591215Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
A118561(CA)
Neonatal-Perinatal Medicine PhysicianPrimary
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
A118561(CA)
Research & Publications (20)
Mechanism of shortened bones in mucopolysaccharidosis VII.
PMID 19375967·Mol Genet Metab·2009
7-preclinical
Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice.
PMID 18613275·J Gene Med·2008
7-preclinical
Immune response hinders therapy for lysosomal storage diseases.
PMID 18654672·J Clin Invest·2008
7-preclinical
Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice.
PMID 18479957·Mol Genet Metab·2008
7-preclinical
Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy.
PMID 18707908·Mol Genet Metab·2008
7-preclinical
Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI.
PMID 18509743·J Inherit Metab Dis·2008
7-preclinical
Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
PMID 16979922·Mol Genet Metab·2007
7-preclinical
High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.
PMID 17596134·J Thromb Haemost·2007
7-preclinical
Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy.
PMID 17519893·Mol Ther·2007
7-preclinical
Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation.
PMID 17311010·Mol Ther·2007
7-preclinical
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice.
PMID 17095052·Thromb Res·2007
7-preclinical
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA.
PMID 16643202·Haemophilia·2006
6-review
Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.
PMID 17015675·J Immunol·2006
7-preclinical
Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig.
PMID 16698321·Mol Ther·2006
4-observational
Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
PMID 16275036·Mol Genet Metab·2006
7-preclinical
C/EBPbeta contributes to hepatocyte growth factor-induced replication of rodent hepatocytes.
PMID 15922473·J Hepatol·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 725 WELCH RD
PALO ALTO, CA 94304 - Phone
- (650) 497-8000
Quick Facts
- NPI
- 1649591215
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile